The REMAP-CAP Investigators
15  results:
Search for persons X
?
2

Coronavirus disease 2019 subphenotypes and differential tre..:

Fish, M. ; Rynne, J. ; Jennings, A....
Intensive Care Medicine.  48 (2022)  11 - p. 1525-1538 , 2022
 
?
4

Virological Characterization of Critically Ill Patients Wit..:

Ratcliff, Jeremy ; Nguyen, Dung ; Fish, Matthew...
The Journal of Infectious Diseases.  224 (2021)  4 - p. 595-605 , 2021
 
?
6

Effect of Antiplatelet Therapy on Survival and Organ Suppor..:

Investigators, REMAP-CAP Writing Committee for the REMAP-CAP ; Dark, Paul
Investigators , REMAP-CAP W C F T REMAP-CAP & Dark , P 2022 , ' Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. ' , JAMA , vol. 327 , no. 13 , pp. 1247-1259 . https://doi.org/10.1001/jama.2022.2910.  , 2022
 
?
9

Therapeutic Anticoagulation with Heparin in Noncritically I..:

Investigators, REMAP-CAP ; Dark, Paul
Investigators , REMAP-CAP & Dark , P 2021 , ' Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. ' , The New England Journal of Medicine , vol. 385 , no. 9 , pp. 790-802 . https://doi.org/10.1056/NEJMoa2105911.  , 2021
 
?
10

Lopinavir-ritonavir and hydroxychloroquine for critically i..:

Investigators, REMAP-CAP ; Dark, Paul
Investigators , REMAP-CAP & Dark , P 2021 , ' Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. ' , Intensive care medicine , vol. 47 , no. 8 , pp. 867-886 . https://doi.org/10.1007/s00134-021-06448-5.  , 2021
 
?
13

Therapeutic Anticoagulation with Heparin in Critically Ill ..:

Investigators, REMAP-CAP ; Dark, Paul
Investigators , REMAP-CAP & Dark , P 2021 , ' Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 ' , The New England Journal of Medicine , vol. 385 , no. 9 , pp. 777-789 . https://doi.org/10.1056/NEJMoa2103417.  , 2021
 
?
14

Effect of Angiotensin-Converting Enzyme Inhibitor and Angio..:

Investigators, Writing Committee for the REMAP-CAP ; Dark, Paul
Investigators , W C F T REMAP-CAP & Dark , P 2023 , ' Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial. ' , JAMA . https://doi.org/10.1001/jama.2023.4480.  , 2023
 
?
15

Effect of Convalescent Plasma on Organ Support-Free Days in..:

Investigators, Writing Committee for the REMAP-CAP ; Dark, Paul
Investigators , W C F T REMAP-CAP & Dark , P 2021 , ' Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial ' , JAMA , vol. 326 , no. 17 , pp. 1690-1702 . https://doi.org/10.1001/jama.2021.18178.  , 2021
 
1-15